191 related articles for article (PubMed ID: 17876342)
1. PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients.
Hor SY; Lee SC; Wong CI; Lim YW; Lim RC; Wang LZ; Fan L; Guo JY; Lee HS; Goh BC; Tan T
Pharmacogenomics J; 2008 Apr; 8(2):139-46. PubMed ID: 17876342
[TBL] [Abstract][Full Text] [Related]
2. Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4alpha, and constitutive androstane receptor with docetaxel pharmacokinetics.
Tham LS; Holford NH; Hor SY; Tan T; Wang L; Lim RC; Lee HS; Lee SC; Goh BC
Clin Cancer Res; 2007 Dec; 13(23):7126-32. PubMed ID: 18056193
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients.
Chew SC; Lim J; Singh O; Chen X; Tan EH; Lee EJ; Chowbay B
Eur J Clin Pharmacol; 2014 Feb; 70(2):155-66. PubMed ID: 24193570
[TBL] [Abstract][Full Text] [Related]
4. PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients.
Sandanaraj E; Lal S; Selvarajan V; Ooi LL; Wong ZW; Wong NS; Ang PC; Lee EJ; Chowbay B
Clin Cancer Res; 2008 Nov; 14(21):7116-26. PubMed ID: 18981011
[TBL] [Abstract][Full Text] [Related]
5. Effects of intrauterine undernutrition on the expression of CYP3A23/3A1, PXR, CAR and HNF4alpha in neonate rats.
Ni S; Wang X; Wang J; Lu S; Zeng S; Zhao Z; Yu L; Chen S
Biopharm Drug Dispos; 2008 Dec; 29(9):501-10. PubMed ID: 19058292
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy.
Kim KP; Ahn JH; Kim SB; Jung KH; Yoon DH; Lee JS; Ahn SH
Cancer Chemother Pharmacol; 2012 May; 69(5):1221-7. PubMed ID: 22271208
[TBL] [Abstract][Full Text] [Related]
7. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression.
Li T; Chiang JY
Drug Metab Dispos; 2006 May; 34(5):756-64. PubMed ID: 16455805
[TBL] [Abstract][Full Text] [Related]
8. The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4.
Tirona RG; Lee W; Leake BF; Lan LB; Cline CB; Lamba V; Parviz F; Duncan SA; Inoue Y; Gonzalez FJ; Schuetz EG; Kim RB
Nat Med; 2003 Feb; 9(2):220-4. PubMed ID: 12514743
[TBL] [Abstract][Full Text] [Related]
9. The nuclear receptors constitutive androstane receptor and pregnane X receptor cross-talk with hepatic nuclear factor 4alpha to synergistically activate the human CYP2C9 promoter.
Chen Y; Kissling G; Negishi M; Goldstein JA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1125-33. PubMed ID: 15919766
[TBL] [Abstract][Full Text] [Related]
10. Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study.
Alba E; Martín M; Ramos M; Adrover E; Balil A; Jara C; Barnadas A; Fernández-Aramburo A; Sánchez-Rovira P; Amenedo M; Casado A;
J Clin Oncol; 2004 Jul; 22(13):2587-93. PubMed ID: 15226326
[TBL] [Abstract][Full Text] [Related]
11. Distribution of the FcgammaRIIIa 176 F/V polymorphism amongst healthy Chinese, Malays and Asian Indians in Singapore.
Chong KT; Ho WF; Koo SH; Thompson P; Lee EJ
Br J Clin Pharmacol; 2007 Mar; 63(3):328-32. PubMed ID: 16981896
[TBL] [Abstract][Full Text] [Related]
12. Genetic variations of NR2A1 in Asian populations: implications in pharmacogenetics studies.
Chew SC; Lim JS; Lee EJ; Chowbay B
Drug Metab Pharmacokinet; 2013; 28(3):278-88. PubMed ID: 23268925
[TBL] [Abstract][Full Text] [Related]
13. Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha.
Ding X; Lichti K; Kim I; Gonzalez FJ; Staudinger JL
J Biol Chem; 2006 Sep; 281(36):26540-51. PubMed ID: 16825189
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of PPARalpha by phenobarbital in the absence of CAR and PXR.
Tamasi V; Juvan P; Beer M; Rozman D; Meyer UA
Mol Pharm; 2009; 6(5):1573-81. PubMed ID: 19708687
[TBL] [Abstract][Full Text] [Related]
15. Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients.
Lal S; Wong ZW; Jada SR; Xiang X; Chen Shu X; Ang PC; Figg WD; Lee EJ; Chowbay B
Pharmacogenomics; 2007 Jun; 8(6):567-75. PubMed ID: 17559346
[TBL] [Abstract][Full Text] [Related]
16. Lower expression of HNF4α and PGC1α might impair rifampicin-mediated CYP3A4 induction under conditions where PXR is overexpressed in human fetal liver cells.
Takezawa T; Matsunaga T; Aikawa K; Nakamura K; Ohmori S
Drug Metab Pharmacokinet; 2012; 27(4):430-8. PubMed ID: 22333269
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogenetics.
Lamba J; Lamba V; Schuetz E
Curr Drug Metab; 2005 Aug; 6(4):369-83. PubMed ID: 16101575
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of target genes across doxorubicin disposition pathway: a review.
Lal S; Mahajan A; Chen WN; Chowbay B
Curr Drug Metab; 2010 Jan; 11(1):115-28. PubMed ID: 20302569
[TBL] [Abstract][Full Text] [Related]
19. Variation of the platelet glycoprotein IIIa PI(A1/A2) allele frequencies in the three ethnic groups of Singapore.
Lim J; Lal S; Ng KC; Ng KS; Saha N; Heng CK
Int J Cardiol; 2003 Aug; 90(2-3):269-73. PubMed ID: 12957761
[TBL] [Abstract][Full Text] [Related]
20. Nuclear receptor coactivator 6 mediates the synergistic activation of human cytochrome P-450 2C9 by the constitutive androstane receptor and hepatic nuclear factor-4alpha.
Surapureddi S; Rana R; Reddy JK; Goldstein JA
Mol Pharmacol; 2008 Sep; 74(3):913-23. PubMed ID: 18552123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
